ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173046; 2) Community: the network communities that were significantly associated with the response to NSC 173046; 3) Molecule: the relationships between components within communities and NSC 173046; 4) MDR: the compounds that were significantly associated with the NSC 173046.

NSC Compound Enrichment Correlation
NSC 224131 N-Phosphonacetyl-L-aspartate 0.0273071169565314 0.16081614
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0273071169565314 0.064878446
NSC 371488 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride 0.0273071169565314 0.015385904
NSC 376111 PANCRATIUM LITTORALE (B844009K071) 0.0273071169565314 0.28476999
NSC 378734 From Cephalodiscus gilchristi 0.0273071169565314 0.10164329
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.0273071169565314 0.1016513
NSC 600684 Null 0.0273071169565314 0.11422856
NSC 610458 Camptothecin Derivative 0.0273071169565314 -0.01014375
NSC 617562 Null 0.0273071169565314 0.22019719
NSC 624659 ANTINEOPLASTIC-624659 0.0273071169565314 0.31856055
Total:91  Current:50    [First] [Prev] [Next] [Last]